telmisartan has been researched along with Infarction, Middle Cerebral Artery in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, JH; Guo, JH; Li, YY; Liu, YQ; Zhu, CH | 1 |
| Bu, M; Gao, Y; Li, M; Li, W; Liu, Y; Wang, Y; Zhang, J | 1 |
| Chen, Y; Li, T; Wu, C; Zhang, Y; Zhu, B | 1 |
| Abe, K; Deguchi, K; Hishikawa, N; Ikeda, Y; Kamiya, T; Kozuki, M; Kurata, T; Lukic, V; Matsuzono, K; Miyazaki, K; Morimoto, N; Ohta, Y; Wada, D; Yamashita, T | 1 |
| Abe, K; Deguchi, K; Fukui, Y; Hishikawa, N; Kurata, T; Lukic, V; Sato, K; Yamashita, T | 1 |
| Abe, K; Deguchi, K; Hishikawa, N; Kurata, T; Morimoto, N; Ohta, Y; Yamashita, T; Zhai, Y | 1 |
| Abe, K; Deguchi, K; Hishikawa, N; Kono, S; Kurata, T; Omote, Y; Sato, K; Yamashita, T | 1 |
| Hori, T; Kawamata, T; Kobayashi, M; Kobayashi, T; Okada, Y; Shibata, N | 1 |
| Horiuchi, M; Iwai, M; Iwanami, J; Jing, F; Min, LJ; Mogi, M; Sakata, A; Tsukuda, K | 1 |
| Horiuchi, M; Inaba, S; Iwai, M; Iwanami, J; Kanno, H; Mogi, M; Tomono, Y | 1 |
10 other study(ies) available for telmisartan and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
PPARγ Activation-Mediated Egr-1 Inhibition Benefits Against Brain Injury in an Experimental Ischaemic Stroke Model.
Topics: Animals; Anti-Inflammatory Agents; Brain; Claudin-5; Disease Models, Animal; Early Growth Response Protein 1; Infarction, Middle Cerebral Artery; Male; PPAR gamma; Rats, Sprague-Dawley; Signal Transduction; Telmisartan | 2020 |
Effect of Telmisartan on Preventing Learning and Memory Deficits Via Peroxisome Proliferator-Activated Receptor-γ in Vascular Dementia Spontaneously Hypertensive Rats.
Topics: Acetylcholinesterase; Animals; Behavior, Animal; Benzimidazoles; Benzoates; Choline O-Acetyltransferase; Dementia, Vascular; Disease Models, Animal; Drug Partial Agonism; GPI-Linked Proteins; Hippocampus; Infarction, Middle Cerebral Artery; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Maze Learning; Memory; Nootropic Agents; PPAR gamma; Rats, Inbred SHR; Signal Transduction; Synaptophysin; Telmisartan | 2018 |
Telmisartan regulates the development of cerebral ischemia by alleviating endoplasmic reticulum stress.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Brain; Caspase 12; Endoplasmic Reticulum Stress; Heat-Shock Proteins; Infarction, Middle Cerebral Artery; Lateral Ventricles; Male; Neurons; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Telmisartan; Transcription Factor CHOP | 2018 |
Long-term effect of telmisartan on Alzheimer's amyloid genesis in SHR-SR after tMCAO.
Topics: Age Factors; Amyloid beta-Peptides; Analysis of Variance; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Body Weight; Brain; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Functional Laterality; Hippocampus; Infarction, Middle Cerebral Artery; Longitudinal Studies; Male; Plaque, Amyloid; Rats; Rats, Inbred SHR; Telmisartan; Triglycerides | 2015 |
Telmisartan reduces progressive oxidative stress and phosphorylated α-synuclein accumulation in stroke-resistant spontaneously hypertensive rats after transient middle cerebral artery occlusion.
Topics: Aldehydes; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Brain; Glycation End Products, Advanced; Hypertension; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Oxidative Stress; Phosphorylation; Rats; Rats, Inbred SHR; Rats, Wistar; Synucleins; Telmisartan | 2014 |
Strong improvement of apolipoprotein E/low-density lipoprotein receptor signals by telmisartan in poststroke spontaneously hypertensive stroke resistant.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Benzimidazoles; Benzoates; Cerebral Cortex; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Male; Mitogen-Activated Protein Kinase 1; Rats; Rats, Inbred SHR; Receptors, LDL; Reperfusion Injury; Signal Transduction; Stroke; Telmisartan | 2014 |
Neurovascular protection by telmisartan via reducing neuroinflammation in stroke-resistant spontaneously hypertensive rat brain after ischemic stroke.
Topics: Acetylglucosamine; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Carrier Proteins; Cerebral Cortex; Collagen Type IV; Disease Models, Animal; Encephalitis; Glial Fibrillary Acidic Protein; Hypertension; Infarction, Middle Cerebral Artery; Inflammasomes; Male; Matrix Metalloproteinase 9; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; Rats, Inbred SHR; Telmisartan; Time Factors | 2015 |
Angiotensin II type 1 receptor blocker telmisartan reduces cerebral infarct volume and peri-infarct cytosolic phospholipase A(2) level in experimental stroke.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biomarkers; Brain; Brain Infarction; Brain Ischemia; Cytoprotection; Cytosol; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Immunohistochemistry; Infarction, Middle Cerebral Artery; Male; Motor Cortex; Neurons; Phospholipases A2; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Recovery of Function; Signal Transduction; Stroke; Telmisartan | 2009 |
Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Benzimidazoles; Benzoates; Blood Flow Velocity; Blood Pressure; Cerebral Cortex; Cytokines; Diabetes Mellitus, Experimental; Drug Antagonism; Drug Therapy, Combination; Infarction, Middle Cerebral Artery; Losartan; Male; Mice; Mice, Inbred C57BL; PPAR gamma; Superoxides; Telmisartan | 2010 |
Attenuation of focal brain ischemia by telmisartan, an angiotensin II type 1 receptor blocker, in atherosclerotic apolipoprotein E-deficient mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Benzimidazoles; Benzoates; Brain Ischemia; Cerebrovascular Circulation; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Mice; Mice, Knockout; Superoxides; Telmisartan | 2008 |